Inspiration Healthcare Group PLC Update regarding NPXe plc (2195A)
May 28 2019 - 1:01AM
UK Regulatory
TIDMIHC
RNS Number : 2195A
Inspiration Healthcare Group PLC
28 May 2019
28 May 2019
Inspiration Healthcare Group plc
("Inspiration Healthcare", or the "Company")
Update regarding NPXe plc
(formerly Neuroprotexeon Limited)
Inspiration Healthcare Group plc (AIM:IHC), the global medical
technology company notes that further to the statement made on 7
December 2018 regarding the potential IPO of NPXe plc, it has
recently been informed that NPXe plc is no longer looking to IPO in
the UK but is pursuing a private offering in the USA, which will be
conducted under US securities law.
UK Investors remain able to participate in this private offering
which is eligible for EIS/VCT relief and should contact NPXe plc
directly should they wish to do so. Further announcements will be
made should the Company be made aware of material developments.
Enquiries:
Inspiration Healthcare Group Tel: 01455 840555
plc
Neil Campbell, Chief Executive
Officer
Mike Briant, Chief Financial
Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Mark Connelly
Cameron MacRitchie
-------------------
Cadogan PR Tel: 07771 713608
Alex Walters
-------------------
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in critical care & operating
theatres. The Company provides high quality innovative products to
patients around the world which help to improve patient outcomes
and it actively invests in innovative product opportunities and
disruptive technologies.
Through investment in research and development the Company has 6
key own brand products that can be used within the first 6 hours of
life to help premature and sick babies; helping with assessment,
resuscitation, stabilisation as well as preventing brain damage.
Additionally the Company has its own range of products for
maintaining normothermia pre- during and post-surgery.
With product availability extending to over 50 countries through
a distribution network, Inspiration Healthcare's success has been
built on continuous innovation, excellent customer service and an
inherent commitment to improving patient outcomes, working in close
collaboration with key opinion leaders across the globe.
In the UK and Ireland the Company has a direct sales team
selling Inspiration Branded and complementary products from third
parties, with an additional range of home healthcare products. This
is supported by Technical Support for planned preventative
maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at
www.inspiration-healthcare.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDQDLFLKEFFBBD
(END) Dow Jones Newswires
May 28, 2019 02:01 ET (06:01 GMT)
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From Apr 2024 to May 2024
Inspiration Healthcare (LSE:IHC)
Historical Stock Chart
From May 2023 to May 2024